BlackRock Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$526M Buy
3,662,040
+67,828
+2% +$9.08M 0.25% 88
2016
Q3
$450M Buy
3,594,212
+115,934
+3% +$15M 0.23% 98
2016
Q2
$457M Sell
3,478,278
-75,609
-2% -$10.3M 0.24% 95
2016
Q1
$494M Sell
3,553,887
-53,587
-1% -$7.16M 0.27% 81
2015
Q4
$503M Buy
3,607,474
+333,170
+10% +$45.9M 0.28% 75
2015
Q3
$458M Buy
3,274,304
+90,203
+3% +$13.6M 0.27% 80
2015
Q2
$523M Buy
3,184,101
+629,099
+25% +$101M 0.29% 74
2015
Q1
$395M Buy
2,555,002
+195,327
+8% +$27.8M 0.21% 101
2014
Q4
$297M Buy
2,359,675
+153,268
+7% +$18.9M 0.16% 143
2014
Q3
$264M Sell
2,206,407
-34,088
-2% -$3.91M 0.15% 146
2014
Q2
$241M Buy
2,240,495
+74,108
+3% +$7.64M 0.14% 164
2014
Q1
$216M Sell
2,166,387
-131,855
-6% -$11.9M 0.14% 166
2013
Q4
$212M Sell
2,298,242
-132,514
-5% -$11.8M 0.14% 167
2013
Q3
$203M Buy
2,430,756
+266,333
+12% +$22.8M 0.14% 166
2013
Q2
$177M Buy
+2,164,423
New +$162M 0.13% 174

Other funds holding ELV